磷酸奥司他韦绿色合成研究进展
Research Progress on Green Synthesis of Oseltamivir Phosphate
DOI: 10.12677/jocr.2026.141011, PDF,    科研立项经费支持
作者: 刘 涛, 任家强, 梁继超*：湖北大学健康科学与工程学院药学系，湖北 武汉；刘 义*：湖北汇中制药有限公司，湖北 黄冈
关键词: 磷酸奥司他韦；绿色合成；工艺优化；Oseltamivir Phosphate； Green Synthesis； Process Optimization
摘要: 流感是一种严重的呼吸道疾病，其治疗主要依赖神经氨酸酶抑制剂。1999年获批的磷酸奥司他韦(商品名：达菲)是目前最有效的口服抗流感神经氨酸酶抑制剂之一。然而，传统的达菲合成工艺存在两大关键缺陷，一是需要使用叠氮化合物，叠氮化合物容易发生爆炸，在工业规模合成中存在显著安全隐患；二是达菲合成的起始原料莽草酸是一种天然产物，主要来源是中国植物八角，其供应稳定性难以满足工业化生产需求。迄今已发展出70余种合成路线。本文系统综述了其中具有代表性的绿色合成路径，为未来的工业合成优化提供方向。
Abstract: Influenza is a severe respiratory disease whose treatment requires neuraminidase inhibitors. Oseltamivir phosphate (Tamiflu), approved in 1999, is one of the most effective oral anti-influenza neuraminidase inhibitors. The traditional synthesis of Tamiflu suffers from two major drawbacks: first, the use of explosive azide compounds, which poses significant safety hazards in industrial-scale synthesis; second, reliance on shikimic acid as the starting material. As a natural product mainly derived from Chinese star anise, shikimic acid faces challenges in stable supply for industrial production. Consequently, over 70 synthetic routes have been developed to date. This article reviews representative optimized synthetic approaches that address these limitations, providing insights for future industrial process optimization toward greener and more efficient production.
文章引用：刘涛, 任家强, 刘义, 梁继超. 磷酸奥司他韦绿色合成研究进展[J]. 有机化学研究, 2026, 14(1): 118-126. https://doi.org/10.12677/jocr.2026.141011

参考文献

[1] Magano, J. (2011) Recent Synthetic Approaches to Oseltamivir Phosphate (Tamiflu™) for the Treatment of Influenza. Tetrahedron, 67, 7875-7899. [Google Scholar] [CrossRef] 
[2] Magano, J. (2009) Synthetic Approaches to the Neuraminidase Inhibitors Zanamivir (Relenza) and Oseltamivir Phosphate (Tamiflu) for the Treatment of Influenza. Chemical Reviews, 109, 4398-4438. [Google Scholar] [CrossRef] [PubMed]
[3] He, G., Massarella, J. and Ward, P. (1999) Clinical Pharmacokinetics of the Prodrug Oseltamivir and Its Active Metabolite Ro 64-0802. Clinical Pharmacokinetics, 37, 471-484. [Google Scholar] [CrossRef] [PubMed]
[4] Davies, B.E. (2010) Pharmacokinetics of Oseltamivir: An Oral Antiviral for the Treatment and Prophylaxis of Influenza in Diverse Populations. Journal of Antimicrobial Chemotherapy, 65, ii5-ii10. [Google Scholar] [CrossRef] [PubMed]
[5] Feng, E., Ye, D., Li, J., Zhang, D., Wang, J., Zhao, F., Hilgenfeld, R., Zheng, M., Jiang, H. and Liu, H. (2012) Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs. ChemMedChem, 7, 1527-1536. [Google Scholar] [CrossRef] [PubMed]
[6] Sharma, P.P., Roy, R. and Chaudhary, A. (2010) Neuraminidase Inhibitors: Oseltamivir, Peramivir, Synthesis and Pro-file. Journal of Pharmacy Research, 3, 1602.
[7] Kim, C.U., Lew, W., Williams, M.A., Liu, H., Zhang, L., Swaminathan, S., et al. (1997) Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity. Journal of the American Chemical Society, 119, 681-690. [Google Scholar] [CrossRef] [PubMed]
[8] Kim, C.U., Lew, W., Williams, M.A., Wu, H., Zhang, L., Chen, X., et al. (1998) Structure-Activity Relationship Studies of Novel Carbocyclic Influenza Neuraminidase Inhibitors. Journal of Medicinal Chemistry, 41, 2451-2460. [Google Scholar] [CrossRef] [PubMed]
[9] Yamatsugu, K., Kamijo, S., Suto, Y., Kanai, M. and Shibasaki, M. (2007) A Concise Synthesis of Tamiflu: Third Generation Route via the Diels-Alder Reaction and the Curtius Rearrangement. Tetrahedron Letters, 48, 1403-1406. [Google Scholar] [CrossRef] 
[10] Fitzpatrick, D.E., Battilocchio, C. and Ley, S.V. (2016) Enabling Technologies for the Future of Chemical Synthesis. ACS Central Science, 2, 131-138. [Google Scholar] [CrossRef] [PubMed]
[11] Gong, J. and Xu, W. (2008) Different Synthetic Strategies of Oseltamivir Phosphate: A Potent Influenza Neuraminidase Inhibitor. Current Medicinal Chemistry, 15, 3145-3159. [Google Scholar] [CrossRef] [PubMed]
[12] Sagandira, C.R., Mathe, F.M., Guyo, U. and Watts, P. (2020) The Evolution of Tamiflu Synthesis, 20 Years on: Advent of Enabling Technologies the Last Piece of the Puzzle? Tetrahedron, 76, Article ID: 131440. [Google Scholar] [CrossRef] [PubMed]
[13] Federspiel, M., Fischer, R., Hennig, M., Mair, H., Oberhauser, T., Rimmler, G., et al. (1999) Industrial Synthesis of the Key Precursor in the Synthesis of the Anti-Influenza Drug Oseltamivir Phosphate (Ro 64-0796/002, GS-4104-02): Ethyl (3r,4s,5s)-4,5-Epoxy-3-(1-ethyl-propoxy)-cyclohex-1-ene-1-carboxylate. Organic Process Research & Development, 3, 266-274. [Google Scholar] [CrossRef] 
[14] Rohloff, J.C., Kent, K.M., Postich, M.J., Becker, M.W., Chapman, H.H., Kelly, D.E., et al. (1998) Practical Total Synthesis of the Anti-Influenza Drug Gs-4104. The Journal of Organic Chemistry, 63, 4545-4550. [Google Scholar] [CrossRef] 
[15] Werner, L., Machara, A. and Hudlicky, T. (2010) Short Chemoenzymatic Azide‐Free Synthesis of Oseltamivir (Tamiflu): Approaching the Potential for Process Efficiency. Advanced Synthesis & Catalysis, 352, 195-200. [Google Scholar] [CrossRef] 
[16] Carr, R., Ciccone, F., Gabel, R., Guinn, M., Johnston, D., Mastriona, J., et al. (2008) Streamlined Process for the Esterification and Ketalization of Shikimic Acid En Route to the Key Precursor for Oseltamivir Phosphate (Tamiflu™). Green Chemistry, 10, 743-745. [Google Scholar] [CrossRef] 
[17] Karpf, M. and Trussardi, R. (2001) New, Azide-Free Transformation of Epoxides into 1,2-Diamino Compounds: Synthesis of the Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate (Tamiflu). The Journal of Organic Chemistry, 66, 2044-2051. [Google Scholar] [CrossRef] [PubMed]
[18] Harrington, P.J., Brown, J.D., Foderaro, T. and Hughes, R.C. (2003) Research and Development of a Second-Generation Process for Oseltamivir Phosphate, Prodrug for a Neuraminidase Inhibitor. Organic Process Research & Development, 8, 86-91. [Google Scholar] [CrossRef] 
[19] Nie, L.-D., Wang, F.-F., Ding, W., Shi, X.-X. and Lu, X. (2013) A Novel Azide-Free Asymmetric Synthesis of Oseltamivir Phosphate (Tamiflu) Starting from Roche’s Epoxide. Tetrahedron: Asymmetry, 24, 638-642. [Google Scholar] [CrossRef] 
[20] Satoh, N., Akiba, T., Yokoshima, S. and Fukuyama, T. (2009) A Practical Synthesis of (−)-Oseltamivir. Tetrahedron, 65, 3239-3245. [Google Scholar] [CrossRef] 
[21] Hayashi, Y. (2021) Time and Pot Economy in Total Synthesis. Accounts of Chemical Research, 54, 1385-1398. [Google Scholar] [CrossRef] [PubMed]
[22] Ishikawa, H., Bondzic, B.P. and Hayashi, Y. (2011) Synthesis of (−)‐Oseltamivir by Using a Microreactor in the Curtius Rearrangement. European Journal of Organic Chemistry, 2011, 6020-6031. [Google Scholar] [CrossRef] 
[23] Zhu, S., Yu, S., Wang, Y. and Ma, D. (2010) Organocatalytic Michael Addition of Aldehydes to Protected 2‐Amino‐1‐nitroethenes: The Practical Syntheses of Oseltamivir (Tamiflu) and Substituted 3‐Aminopyrrolidines. Angewandte Chemie International Edition, 49, 4656-4660. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, Q., Cheng, B., Liu, M. and Chen, F. (2025) A Concise Asymmetric Synthesis of (−)-Oseltamivir Phosphate via a Biphasic Pd-Catalyzed Heck-Type Cyclization. Chinese Chemical Letters, 37, Article ID: 111555. [Google Scholar] [CrossRef] 
[25] Shie, J., Fang, J., Wang, S., Tsai, K., Cheng, Y.E., Yang, A., et al. (2007) Synthesis of Tamiflu and Its Phosphonate Congeners Possessing Potent Anti-Influenza Activity. Journal of the American Chemical Society, 129, 11892-11893. [Google Scholar] [CrossRef] [PubMed]
[26] Tanaka, T., Tan, Q., Kawakubo, H. and Hayashi, M. (2011) Formal Total Synthesis of (−)-Oseltamivir Phosphate. The Journal of Organic Chemistry, 76, 5477-5479. [Google Scholar] [CrossRef] [PubMed]
[27] Chuanopparat, N., Kongkathip, N. and Kongkathip, B. (2012) A New and Efficient Asymmetric Synthesis of Oseltamivir Phosphate (Tamiflu) from D-Mannose. Tetrahedron Letters, 53, 6209-6211. [Google Scholar] [CrossRef] 
[28] Ma, J., Zhao, Y., Ng, S., Zhang, J., Zeng, J., Than, A., et al. (2010) Sugar‐Based Synthesis of Tamiflu and Its Inhibitory Effects on Cell Secretion. Chemistry—A European Journal, 16, 4533-4540. [Google Scholar] [CrossRef] [PubMed]
[29] Kongkathip, B., Akkarasamiyo, S. and Kongkathip, N. (2015) A New and Efficient Asymmetric Synthesis of Oseltamivir Phosphate (Tamiflu) from D-Glucose. Tetrahedron, 71, 2393-2399. [Google Scholar] [CrossRef] 
[30] Sagandira, C.R. and Watts, P. (2019) Efficient Continuous Flow Synthesis of Ethyl Shikimate: The First Step in the Synthesis of Tamiflu. Journal of Flow Chemistry, 9, 79-87. [Google Scholar] [CrossRef] 
[31] Feng, K., Chen, J., Gu, S., Wang, H. and Chen, F. (2024) New Progress of Fully Continuous Flow Reaction Technologies in Pharmaceutical Synthesis (2019~2022). Chinese Journal of Organic Chemistry, 44, Article No. 378. [Google Scholar] [CrossRef] 
[32] Andresini, M., Degannaro, L. and Luisi, R. (2021) A Sustainable Strategy for the Straightforward Preparation of 2h-Azirines and Highly Functionalized nh-Aziridines from Vinyl Azides Using a Single Solvent Flow-Batch Approach. Beilstein Journal of Organic Chemistry, 17, 203-209. [Google Scholar] [CrossRef] [PubMed]
[33] Alfano, A.I., Pelliccia, S., Rossino, G., Chianese, O., Summa, V., Collina, S., et al. (2023) Continuous-Flow Technology for Chemical Rearrangements: A Powerful Tool to Generate Pharmaceutically Relevant Compounds. ACS Medicinal Chemistry Letters, 14, 326-337. [Google Scholar] [CrossRef] [PubMed]
[34] Yoshida, J., Nagaki, A. and Yamada, D. (2013) Continuous Flow Synthesis. Drug Discovery Today: Technologies, 10, e53-e59. [Google Scholar] [CrossRef] [PubMed]
[35] Buglioni, L., Raymenants, F., Slattery, A., Zondag, S.D.A. and Noël, T. (2021) Technological Innovations in Photochemistry for Organic Synthesis: Flow Chemistry, High-Throughput Experimentation, Scale-Up, and Photoelectrochemistry. Chemical Reviews, 122, 2752-2906. [Google Scholar] [CrossRef] [PubMed]
[36] Sagandira, C.R. and Watts, P. (2019) Safe and Highly Efficient Adaptation of Potentially Explosive Azide Chemistry Involved in the Synthesis of Tamiflu Using Continuous-Flow Technology. Beilstein Journal of Organic Chemistry, 15, 2577-2589. [Google Scholar] [CrossRef] [PubMed]
[37] Krämer, M., Bongaerts, J., Bovenberg, R., Kremer, S., Müller, U., Orf, S., et al. (2003) Metabolic Engineering for Microbial Production of Shikimic Acid. Metabolic Engineering, 5, 277-283. [Google Scholar] [CrossRef] [PubMed]
[38] Zhang, B., Zhou, N., Liu, Y., Liu, C., Lou, C., Jiang, C., et al. (2015) Ribosome Binding Site Libraries and Pathway Modules for Shikimic Acid Synthesis with Corynebacterium Glutamicum. Microbial Cell Factories, 14, Article No. 71. [Google Scholar] [CrossRef] [PubMed]
[39] Li, Z., Gao, C., Ye, C., Guo, L., Liu, J., Chen, X., et al. (2023) Systems Engineering of Escherichia Coli for High-Level Shikimate Production. Metabolic Engineering, 75, 1-11. [Google Scholar] [CrossRef] [PubMed]
[40] Rawat, G., Tripathi, P., Jahan, F. and Saxena, R.K. (2013) A Natural Isolate Producing Shikimic Acid: Isolation, Identification, and Culture Condition Optimization. Applied Biochemistry and Biotechnology, 169, 2290-2302. [Google Scholar] [CrossRef] [PubMed]
[41] Ghosh, S. and Banerjee, U.C. (2015) Generation of Aroe Overexpression Mutant of Bacillus Megaterium for the Production of Shikimic Acid. Microbial Cell Factories, 14, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[42] Licona-Cassani, C., Lara, A.R., Cabrera-Valladares, N., Escalante, A., Hernández-Chávez, G., Martinez, A., et al. (2013) Inactivation of Pyruvate Kinase or the Phosphoenolpyruvate: Sugar Phosphotransferase System Increases Shikimic and Dehydroshikimic Acid Yields from Glucose in Bacillus subtilis. Microbial Physiology, 24, 37-45. [Google Scholar] [CrossRef] [PubMed]
[43] Guo, J., Suástegui, M., Sakimoto, K.K., Moody, V.M., Xiao, G., Nocera, D.G., et al. (2018) Light-Driven Fine Chemical Production in Yeast Biohybrids. Science, 362, 813-816. [Google Scholar] [CrossRef] [PubMed]

为你推荐